2023 international evidence-based guideline pcos glp-1 receptor agonist

2023 international evidence-based guideline pcos glp-1 receptor agonist Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the evidence‐based - Goldberg - 2024 - Obesity Reviews Therapeutic targets in polycystic ovary

Name: 2023 international evidence-based guideline pcos glp-1 receptor agonist Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the evidence‐based - Goldberg - 2024 - Obesity Reviews Therapeutic targets in polycystic ovary
Brand: museeartisanaletruralclion.fr
SKU: 26786535859
Price: 26.01 USD
Availability: InStock
Rating: 4.1332 (13 reviews)

SKU: 26786535859

4.1

USD26.01 USD52.01

Pay in 4 interest-free payments of $6.50 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

Description

The resulting alignment between guidelines and reimbursement accelerates specialist and primary-care adoption, expanding the GLP-1 agonists market to previously untapped populations